Evaluating Oxycodone Versus Sufentanil for Patient-Controlled Intravenous Pain Relief After Laparoscopic Hysterectomy

What this Trial Is About

Researchers are evaluating the safety and effectiveness of oxycodone compared to sulfentanil in patient-controlled intravenous analgesia PCIA for managing pain after gynecological laparoscopic hysterectomy. This Phase 4 study aims to find the best PCIA approach to improve postoperative pain control for patients undergoing these surgeries. Participants will be randomly assigned to one of two groups one group will receive sulfentanil through PCIA, while the other group will receive oxycodone through PCIA. Pain levels will be measured using Numeric Rating Scale NRS scores at 1, 6, 24, and 48 hours after surgery. The study will also monitor the use of additional pain relief medications and any adverse events. During the trial, participants will have their pain assessed regularly and will be observed for any side effects or complications within 48 hours post-surgery. Other measures include the number of times the PCIA device is pressed, time to first anal exhaust, and pain scores up to 30 days after surgery. The total participation period includes these assessments to ensure comprehensive monitoring of pain management and safety.

Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy